Qingxin Mu

Aug 3, 2023 | frontiersin.org | Shenzhen Maternity |Qingxin Mu |Dan Wu |Nikhil Pandey

1 IntroductionTriple positive breast cancer (TPBC) is a specific type of breast cancer that lacks estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2), and accounts for approximately 15% of all breast cancer cases (Kudelova et al., 2022; Leon-Ferre and Goetz, 2023).

Mar 22, 2023 | mdpi.com | James Griffin |Yan Wu |Qingxin Mu |Xinyan Li

Open AccessArticlebyJames Griffin 1,†, Yan Wu 2,†,‡, Qingxin Mu 1, Xinyan Li 1,3 and Rodney J. Y. Ho 1,* 1Departments of Pharmaceutics, University of Washington, Seattle, WA 98195, USA2Departments of Bioengineering, University of Washington, Seattle, WA 98195, USA3School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China*Author to whom correspondence should be addressed. †These authors contributed equally to this work.